MEGDEL Syndrome and Its Anesthetic Implications

Area of Science:

• Genetics and rare diseases
• Neuroscience
• Metabolic disorders

Background:

• MEGDEL syndrome is a rare genetic disorder characterized by 3-methylglutaconic aciduria, deafness, encephalopathy, and Leigh-like syndrome.
• It is caused by biallelic mutations in the serine active site-containing protein 1 (SERAC1) gene.
• MEGD(H)EL syndrome is a variant that includes hepatopathy.

Observation:

• This report details the anesthetic management of a neonate diagnosed with MEGD(H)EL syndrome.
• The neonate underwent diagnostic brain magnetic resonance imaging at 14 days of postnatal age.
• The case highlights the importance of understanding this rare condition for anesthesiologists.

Findings:

• MEGD(H)EL syndrome shares pathological features with various inborn errors of metabolism.
• The study emphasizes the need for specialized anesthetic considerations in neonates with MEGD(H)EL syndrome.
• Understanding the epidemiology and clinical features is crucial for perioperative care.

Implications:

• This case report provides valuable insights into the anesthetic management of MEGD(H)EL syndrome.
• It underscores the importance of a multidisciplinary approach for patients with rare genetic metabolic disorders.
• Further research into SERAC1 gene function and MEGD(H)EL syndrome pathophysiology is warranted.